前列腺切除、汽化、剜除--等离子电切

The PLASMA (TURis) system offers an equivalent efficacy to monopolar TURP^8,15 that includes maximum flow rate (Qmax), resection weight/radicality, PVR (Post-Void Residual), and IPSS (International Prostate Symptom Score)/IIEF-5 (International Index of Erectile Function). Clinical outcomes are followed for up to 36 months, which is the longest among the surgical options.¹⁰

Compared to monopolar technology, the PLASMA (TURis) system has a more favorable perioperative safety profile, especially regarding TUR syndrome occurrence, frequency of blood transfusions, and the clot retention rate.¹⁸

The strong safety profile of the PLASMA (TURis) system also results in a reduced average length of hospital stay, shorter catheterization times, and fewer postoperative readmissions.¹⁸